Advertisement
Product › Details
Morphomer® platform
Next higher product group | drug discovery technology_oo | |
Status | 2019-03-21 existent | |
Organisation | AC Immune S.A. (Nasdaq: ACIU) | |
Source | AC Immune S.A.. (3/21/19). "Press Release: AC Immune Reports Full-Year 2018 Financial Results and Provides Business Update". Lausanne. | |
Record changed: 2023-12-20 |
Advertisement
More documents for drug discovery technology_oo
- [1] Nuclera Ltd.. (10/16/24). "Press Release: Nuclera Closes $75 Million USD Financing > Series C round led by Elevage Medical Technologies". Cambridge & Boston, MA....
- [2] PhoreMost Ltd.. (9/10/24). "Press Release: PhoreMost Extends Series B Financing to $50M to Advance High-value Oncology and Inflammation Degrader Programmes". Cambridge....
- [3] Macomics Ltd.. (6/10/24). "Press Release: Macomics Announces Appointment of Simon Dew as New Chief Business Officer". Edinburgh & Cambridge....
- [4] Quantro Therapeutics GmbH. (6/4/24). "Press Release: Quantro Therapeutics Reaches a Milestone in the Collaboration with Boehringer Ingelheim to Develop First-in-Class Cancer Treatments". Vienna....
- [5] LabGenius. (5/21/24). "Press Release: LabGenius Raises £35 Million Led by M Ventures to Further Develop Its ML-driven Antibody Discovery Platform and Progress a Pipeline of Assets Towards the Clinic". London....
- [6] Memo Therapeutics AG. (5/7/24). "Press Release: Memo Therapeutics Increases Series C Financing to CHF 45 Million". Schlieren....
- [7] PeptiDream Inc.. (4/30/24). "Press Release: PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis". Kanagawa....
- [8] Neurolentech GmbH. (4/22/24). "Press Release: Neurolentech Signs Technology Access Partnership with Kaerus Bioscience to Advance Neurodevelopmental Disorder Research". Klosterneuburg....
- [9] BioCopy AG. (4/9/24). "Press Release: BioCopy Expands Corporate Portfolio with Acquisition of Perspix Biotech GmbH". Basel....
- [10] Nuclera Ltd.. (2/7/24). "Press Release: Nuclera Partners with Sharp Life Science Advancing Its Digital Microfluidics Capability"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top